Gene was diagnosed with Stage 4 Metastatic Pancreatic Cancer in late December 2018. He quickly learned that, unlike many other strains of cancer where breakthroughs in treatment and cure have occurred over the last 10 years, Pancreatic Cancer has had no such breakthroughs.
With Dr. Heinz-Josef Lenz, and the entire team at USC Norris Comprehensive Cancer Center at his side, Gene survived for 27 months following his diagnosis in December, 2018.
Prior to Gene’s passing on March 20, 2021, Gene and Dodie created the Gene and Dodie Gregg Pancreatic Cancer Research Fund at USC Norris Comprehensive Cancer Center with the goal of promoting ongoing and future research directed to discovering successful treatment and cure options. The Gregg Family, along with Dr. Lenz, constitute the Advisory Board of the Fund. Dr. Lenz also initially serves in the capacity of Primary Investigator (heading the research team). Dr. Lenz and his team have launched the research initiative dedicated to applying novel approaches to discover effective treatments and/or cures for Pancreatic Cancer.
The Gregg Family vision for the fund is to foster realistic hope to all those impacted by this terrible disease by helping not only to advance important and essential translational research into effective treatment and cure options, but also to help spread the word to others who may wish to provide their support.